Improper function of certain messenger materials in the body that control body weight and hunger in research hub

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial: Multiple Independent Sub-studies of Setmelanotide in Patients with POMC/PCSK1, LEPR, NCOA1 (SRC1), or SH2B1 Gene Variants in the Melanocortin-4 Receptor Pathway

This study looks at a medicine called setmelanotide for people who struggle with severe weight issues and extreme hunger caused by rare genetic changes. Researchers want to find out if daily injections under the skin can help adults safely reduce hunger and manage their weight over one year.